Editas Medicine (EDIT)
1.5400 x 2 1.5800 x 14
Post-market by (Cboe BZX)
1.5800 +0.0400 (+2.60%) 04/28/25 [NASDAQ]
1.5400 x 2 1.5800 x 14
Post-market 1.5799 -0.0001 (-0.01%) 18:05 ET
for Mon, Apr 28th, 2025
Results
download Want to compare other data? Select Fields| Symbol | EDIT | FATE | KYTX | ||
| Company | Editas Medicine | Fate Therapeutics | Kyverna Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.5700 | 1.2800 | 2.11 | ||
| High | 1.7100 | 1.3100 | 2.13 | ||
| Low | 1.5300 | 1.2300 | 2.00 | ||
| Last | 1.5800 | 1.2500 | 2.05 | ||
| Change | +0.0400 | -0.0300 | -0.05 | ||
| % Change | +2.60% | -2.34% | -2.38% | ||
| Volume | 1,925,875 | 1,141,620 | 119,429 | ||
| 20-Day Average Volume | 2,180,494 | 2,523,666 | 256,411 | ||
| Previous Close | 1.5400 | 1.2800 | 2.10 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.2780 | 1.0262 | 2.00 | ||
| 20-Day Raw Stochastic | 83.75% | 71.05% | 55.10% | ||
| 20-Day Relative Strength | 55.81% | 55.97% | 43.91% | ||
| Weighted Alpha | -71.43 | -73.69 | -86.36 | ||
| Today's Opinion | 24% Sell | 56% Sell | 88% Sell | ||
| Previous Opinion | 24% Sell | 56% Sell | 88% Sell | ||
| Last Month's Opinion | 80% Sell | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +18.80% since 04/21/25 | unch since 04/21/25 | +3.02% since 04/21/25 | ||
| Low | 1.3800 on 04/22/25 | 1.2300 on 04/28/25 | 1.92 on 04/22/25 | ||
| High | 1.7100 on 04/28/25 | 1.4900 on 04/23/25 | 2.23 on 04/23/25 | ||
| 1-Month | |||||
| %Chg | +26.40% since 03/28/25 | +47.18% since 03/28/25 | +2.50% since 03/28/25 | ||
| Low | 0.9100 on 04/07/25 | 0.6611 on 04/04/25 | 1.78 on 04/17/25 | ||
| High | 1.7100 on 04/28/25 | 1.4900 on 04/23/25 | 2.27 on 04/14/25 | ||
| 3-Month | |||||
| %Chg | +11.27% since 01/28/25 | -3.85% since 01/28/25 | -42.58% since 01/28/25 | ||
| Low | 0.9100 on 04/07/25 | 0.6611 on 04/04/25 | 1.78 on 04/17/25 | ||
| High | 3.2999 on 02/19/25 | 1.8100 on 02/19/25 | 3.64 on 01/29/25 | ||
| 6-Month | |||||
| %Chg | -51.53% since 10/28/24 | -56.45% since 10/28/24 | -61.47% since 10/28/24 | ||
| Low | 0.9100 on 04/07/25 | 0.6611 on 04/04/25 | 1.78 on 04/17/25 | ||
| High | 3.4000 on 11/06/24 | 3.5000 on 11/18/24 | 7.20 on 12/02/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 86,221 | 86,285 | 85,574 | ||
| Shares Outstanding, K | 83,710 | 114,604 | 43,219 | ||
| Annual Sales | 32,310,000 | 13,630,000 | 0 | ||
| Annual Net Income | -237,090,000 | -186,260,000 | -127,480,000 | ||
| Last Quarter Sales | 30,610,000 | 1,860,000 | 0 | ||
| Last Quarter Net Income | -45,390,000 | -52,150,000 | -37,490,000 | ||
| 60-Month Beta | 2.16 | 2.41 | 2.57 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.55 on 03/05/25 | -0.31 on 03/05/25 | -0.88 on 03/27/25 | ||
| Latest Earnings Date | 05/14/25 | 05/08/25 | 05/13/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||